lemtrada 12mg/1.2ml
sanofi-aventis d.o.o. beograd - алемтузумаб - koncentrat za rastvor za infuziju - 12mg/1.2ml
lemtrada 12mg/1.2ml
amicus srb d.o.o. - алемтузумаб - koncentrat za rastvor za infuziju - 12mg/1.2ml
lemtrada 10 mg/ml konzentrat zur herstellung einer infusionslösung
sanofi-aventis (suisse) sa - alemtuzumabum - konzentrat zur herstellung einer infusionslösung - alemtuzumabum 10 mg, natrii chloridum, dinatrii phosphas dihydricus, kalii chloridum, kalii dihydrogenophosphas, polysorbatum 80, dinatrii edetas, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - multiple sklerose - biotechnologika
lemtrada 10 mg/ml concentrat pentru soluţie perfuzabilă
sanofi belgium - alemtuzumabum - concentrat pentru soluţie perfuzabilă - 10 mg/ml
lemtrada (▼) 12 mg/1 bočica koncentrat za rastvor za infuziju
sanofi d.o.o. - alemtuzumab - koncentrat za rastvor za infuziju - 12 mg/1 bočica - 1 ml koncentrata za rastvor za infuziju sadrži: 10 mg alemtuzumaba
lemtrada 12 mg concentrate for solution for infusion
genzyme therapeutics ltd - alemtuzumab - concentrate for solution for infusion - 12 mg alemtuzumab in 1.2 ml (10 mg/ml) - multiple sclerosis - selective immunosuppressants - indicated for adult patients with relapsing remitting multiple sclerosis (rrms) with active disease defined by clinical or imaging features
lemtrada 12mg1.2ml concentrate for solution for infusion vials
genzyme therapeutics ltd - alemtuzumab - solution for infusion - 10mg/1ml
lemtrada concentrate for solution for infusion 12 mg 1.2 ml
sanofi-aventis singapore pte. ltd. - alemtuzumab - infusion, solution concentrate - alemtuzumab 12 mg/1.2 ml
lemtrada
sanofi belgium - alemtuzumab - margvísleg sclerosis - valdar ónæmisbælandi lyf - lemtrada er ætlað fullorðnum sjúklingum með endurtekna endurtekna mænusigg (rrms) með virkum sjúkdómum sem eru skilgreindar með klínískum eða hugsanlegum eiginleikum.
lemtrada
sanofi belgium - alemtuzumab - sklerosi multipla - immunosuppressanti selettivi - lemtrada huwa indikat għall-pazjenti adulti bl-relapsing-remitting multipli sclerosis (rrms) bil-marda attiva definiti mill-karatteristiċi kliniċi jew tal-immaġnar.